4//SEC Filing
Gurrola Sandra M 4
Accession 0001493152-24-025105
CIK 0000748592other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:32 PM ET
Size
8.9 KB
Accession
0001493152-24-025105
Insider Transaction Report
Form 4
Gurrola Sandra M
VP of Finance
Transactions
- Tax Payment
Common Stock
2024-06-21$1.94/sh−180$349→ 1,185 total - Exercise/Conversion
Common Stock
2024-06-21+437→ 1,365 total - Exercise/Conversion
Restricted Stock Units
2024-06-21−437→ 437 total→ Common Stock (437 underlying)
Footnotes (2)
- [F1]Each restricted stock unit converts into one share of common stock.
- [F2]On June 21, 2021, the reporting person was granted 1,750 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date.
Documents
Issuer
Eterna Therapeutics Inc.
CIK 0000748592
Entity typeother
Related Parties
1- filerCIK 0001618457
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 4:32 PM ET
- Size
- 8.9 KB